2G00
Factor Xa in complex with the inhibitor 3-(6-(2'-((dimethylamino)methyl)-4-biphenylyl)-7-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-1-yl)benzamide
Summary for 2G00
Entry DOI | 10.2210/pdb2g00/pdb |
Descriptor | Coagulation factor X, 3-[6-{2'-[(DIMETHYLAMINO)METHYL]BIPHENYL-4-YL}-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1-YL]BENZAMIDE (3 entities in total) |
Functional Keywords | glycoprotein, hydrolase, serine protease, plasma, blood coagulation factor, protein inhibitor complex, calcium-binding |
Biological source | Homo sapiens (human) More |
Cellular location | Secreted: P00742 P00742 |
Total number of polymer chains | 2 |
Total formula weight | 32569.88 |
Authors | Alexander, R.S. (deposition date: 2006-02-10, release date: 2006-10-03, Last modification date: 2017-10-18) |
Primary citation | Pinto, D.J.,Galemmo, R.A.,Quan, M.L.,Orwat, M.J.,Clark, C.,Li, R.,Wells, B.,Woerner, F.,Alexander, R.S.,Rossi, K.A.,Smallwood, A.,Wong, P.C.,Luettgen, J.M.,Rendina, A.R.,Knabb, R.M.,He, K.,Wexler, R.R.,Lam, P.Y. Discovery of potent, efficacious, and orally bioavailable inhibitors of blood coagulation factor Xa with neutral P1 moieties. Bioorg.Med.Chem.Lett., 16:5584-5589, 2006 Cited by PubMed: 16963264DOI: 10.1016/j.bmcl.2006.08.027 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.1 Å) |
Structure validation
Download full validation report